semaglutide for ckd does affect kidneys In the FLOW trial, researchers assessed whether the glucagon-like peptide 1 Ozempic picks up FDA indication
Description
Combining semaglutide and testosterone replacement therapy may benefit weight management and sexual function in men, but research is limited.

While most people associate GLP-1 with weight-loss injections, this system goes far beyond that

Brand names like Ozempic, Rybelsus, and Wegovy underscore its role in improving health outcomes

The study is published in The Lancet and was funded by the Novo Nordisk Foundation, the company that develops these drugs.
